Radiation myelopathy following transplantation and radiotherapy for non–Hodgkin’s lymphoma

Michael W.T Chao1, Andrew Wirth1, Gail Ryan1, Michael MacManus1, K.H Liew1
1Division of Radiation Oncology, Peter MacCallum Cancer Institute, East Melbourne, Victoria, Australia

Tài liệu tham khảo

Wang, 1993, Magnetic resonance imaging in radiation myelopathy, Am. J. Neuroradiol., 13, 1049 Armitage, 1993, Treatment of non-Hodgkin’s lymphoma, N. Engl. J. Med., 328, 1023, 10.1056/NEJM199304083281409 Armitage, 1994, Bone marrow transplantation, N. Engl. J. Med., 330, 827, 10.1056/NEJM199403243301206 Miles-Prince, 1996, The role of intensive therapy and autologous blood and marrow transplantation for chemotherapy sensitive relapsed and primary refractory Non-hodgkin’s lymphoma, Br. J. Haematol., 92, 880, 10.1046/j.1365-2141.1996.437976.x Reece, 1994, Intensive therapy with cyclophosphamide, carmustine, etoposide ± cisplatin and autologous bone marrow transplantation for Hodgkin’s disease in first relapse after combination therapy, Blood, 83, 1193, 10.1182/blood.V83.5.1193.1193 Stahel, 1995, High dose chemotherapy and autologous bone marrow transplantation for malignant lymphomas, Cancer Treat. Rev., 21, 3, 10.1016/0305-7372(95)90009-8 Philip, 1995, Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy sensitive non-Hodgkin’s lymphoma, N. Engl. J. Med., 333, 1540, 10.1056/NEJM199512073332305 Gainni, 1997, High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma, N. Engl. J. Med., 336, 1290, 10.1056/NEJM199705013361804 Yahalom, 1995, Integrating radiotherapy into bone marrow transplantation programs for Hodgkin’s disease, Int. J. Radiat. Oncol. Biol. Phys., 33, 525, 10.1016/0360-3016(95)02071-I Freedman, 1990, Autologous bone marrow transplantation in B cell Non-hodgkin’s lymphoma, J. Clin. Oncol., 8, 784, 10.1200/JCO.1990.8.5.784 Peterson, 1990, Autologous marrow transplantation for malignant lymphoma, J. Clin. Oncol., 8, 638, 10.1200/JCO.1990.8.4.638 Constine, 1995, Radiotherapy to previously involved sites after auto-transplantation for lymphoma and Hodgkin’s disease, Proc. Am. Soc. Clin. Oncol., 14, 394 Poen, 1996, High dose therapy and autologous bone marrow transplantation for relapsed/refractory Hodgkin’s disease, Int. J. Radiat. Oncol. Biol. Phys., 36, 3, 10.1016/S0360-3016(96)00277-5 Chopra, 1995, BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin’s lymphoma, J. Clin. Oncol., 13, 588, 10.1200/JCO.1995.13.3.588 Pezner, 1995, Involved field radiation therapy for Hodgkin’s disease autologous bone marrow transplantation regimens, Radiother. Oncol., 34, 23, 10.1016/0167-8140(94)01502-T Weaver, 1993, High dose cyclophosphamide, carmustine and etoposide followed by autologous bone marrow transplantation in patients with lymphoid malignancies who have received dose limiting radiation therapy, J. Clin. Oncol., 11, 1329, 10.1200/JCO.1993.11.7.1329 Schulthiess, 1992, Invited review—permanent radiation myelopathy, Br. J. Radiol., 65, 737, 10.1259/0007-1285-65-777-737 Chouchair, 1991, Myelopathies in the cancer patient, Oncology, 5, 25 Feldman, 1986, Episodic neurologic dysfunction in patients with Hodgkin’s disease, Arch. Neurol., 43, 1227, 10.1001/archneur.1986.00520120011009 Bleyer, 1980, White matter necrosis, mineralising microangiopathy and intellectual abilities in survivors of childhood leukemia, 155 Walther, 1987, The development of L’Hermitt’s sign during cisplatin chemotherapy, Cancer, 60, 2170, 10.1002/1097-0142(19871101)60:9<2170::AID-CNCR2820600909>3.0.CO;2-N Lee, 1986, Treatment related white matter changes in cancer patients, Cancer, 57, 1473, 10.1002/1097-0142(19860415)57:8<1473::AID-CNCR2820570807>3.0.CO;2-B Ruckdeschel, 1979, Sequential radiotherapy and adriamycin in the management of bronchogenic carcinoma, Int. J. Radiat. Oncol. Biol. Phys., 5, 1323, 10.1016/0360-3016(79)90663-1 Duncan, 1973, Mass spectrophotometric study of the distribution of cyclophosphamide in humans, Toxicol. Appl. Pharmacol., 24, 317, 10.1016/0041-008X(73)90151-8 Roach, 1993, Alkylating agents, 90 Hartmann, 1986, High-dose busulfan and cyclophosphamide with autologous bone marrow transplantation support in advanced malignancies in children, J. Clin. Oncol., 4, 1804, 10.1200/JCO.1986.4.12.1804